144 related articles for article (PubMed ID: 11216994)
1. Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats.
Lacolley P; Safar ME; Lucet B; Ledudal K; Labat C; Benetos A
J Am Coll Cardiol; 2001 Feb; 37(2):662-7. PubMed ID: 11216994
[TBL] [Abstract][Full Text] [Related]
2. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats.
Benetos A; Lacolley P; Safar ME
Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1152-6. PubMed ID: 9194767
[TBL] [Abstract][Full Text] [Related]
3. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
Brilla CG; Schencking M; Scheer C; Rupp H
Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851
[TBL] [Abstract][Full Text] [Related]
4. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
[TBL] [Abstract][Full Text] [Related]
5. Spironolactone improves carotid artery fibrosis and distensibility in rat post-ischaemic heart failure.
Nehme JA; Lacolley P; Labat C; Challande P; Robidel E; Perret C; Leenhardt A; Safar ME; Delcayre C; Milliez P
J Mol Cell Cardiol; 2005 Sep; 39(3):511-9. PubMed ID: 15992819
[TBL] [Abstract][Full Text] [Related]
6. Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone.
Lacolley P; Labat C; Pujol A; Delcayre C; Benetos A; Safar M
Circulation; 2002 Nov; 106(22):2848-53. PubMed ID: 12451013
[TBL] [Abstract][Full Text] [Related]
7. Differences between cardiac and arterial fibrosis and stiffness in aldosterone-salt rats: effect of eplerenone.
Nehme J; Mercier N; Labat C; Benetos A; Safar ME; Delcayre C; Lacolley P
J Renin Angiotensin Aldosterone Syst; 2006 Mar; 7(1):31-9. PubMed ID: 17083071
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic dihydropyridine (isradipine) on the large arterial walls of spontaneously hypertensive rats.
Levy BI; Duriez M; Phillipe M; Poitevin P; Michel JB
Circulation; 1994 Dec; 90(6):3024-33. PubMed ID: 7994851
[TBL] [Abstract][Full Text] [Related]
9. Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries.
Michel JB; Heudes D; Michel O; Poitevin P; Philippe M; Scalbert E; Corman B; Levy BI
Am J Physiol; 1994 Jul; 267(1 Pt 2):R124-35. PubMed ID: 8048614
[TBL] [Abstract][Full Text] [Related]
10. Induction of cardiac fibrosis by aldosterone.
Lijnen P; Petrov V
J Mol Cell Cardiol; 2000 Jun; 32(6):865-79. PubMed ID: 10888242
[TBL] [Abstract][Full Text] [Related]
11. The effect of aldosterone-antagonist therapy on aortic elastic properties in patients with nonischemic dilated cardiomyopathy.
Vizzardi E; Pina PD; Caretta G; Bonadei I; Sciatti E; Lombardi C; D'Aloia A; Curnis A; Metra M
J Cardiovasc Med (Hagerstown); 2015 Sep; 16(9):597-602. PubMed ID: 24978872
[TBL] [Abstract][Full Text] [Related]
12. Reactive and reparative myocardial fibrosis in arterial hypertension in the rat.
Brilla CG; Weber KT
Cardiovasc Res; 1992 Jul; 26(7):671-7. PubMed ID: 1423431
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone and myocardial fibrosis in heart failure.
Brilla CG
Herz; 2000 May; 25(3):299-306. PubMed ID: 10904856
[TBL] [Abstract][Full Text] [Related]
14. Changes in the composition of the thoracic aortic wall in spontaneously hypertensive rats treated with losartan or spironolactone.
Han WQ; Wu LY; Zhou HY; Zhang J; Che ZQ; Wu YJ; Liu JJ; Zhu DL; Gao PJ
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):583-8. PubMed ID: 19673944
[TBL] [Abstract][Full Text] [Related]
15. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion.
Sun Y; Ramires FJ; Weber KT
Cardiovasc Res; 1997 Jul; 35(1):138-47. PubMed ID: 9302358
[TBL] [Abstract][Full Text] [Related]
16. Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system.
Brown L; Duce B; Miric G; Sernia C
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S143-8. PubMed ID: 9892155
[TBL] [Abstract][Full Text] [Related]
17. Spironolactone and captopril attenuates isoproterenol-induced cardiac remodelling in rats.
Gallego M; Espiña L; Vegas L; Echevarria E; Iriarte MM; Casis O
Pharmacol Res; 2001 Oct; 44(4):311-5. PubMed ID: 11592866
[TBL] [Abstract][Full Text] [Related]
18. Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo.
Brown NJ; Nakamura S; Ma L; Nakamura I; Donnert E; Freeman M; Vaughan DE; Fogo AB
Kidney Int; 2000 Sep; 58(3):1219-27. PubMed ID: 10972684
[TBL] [Abstract][Full Text] [Related]
19. Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension.
Brilla CG; Matsubara LS; Weber KT
Am J Cardiol; 1993 Jan; 71(3):12A-16A. PubMed ID: 8421998
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of angiotensin-converting enzyme inhibition on the arterial wall of adult spontaneously hypertensive rats.
Levy BI; Michel JB; Salzmann JL; Poitevin P; Devissaguet M; Scalbert E; Safar ME
Am J Cardiol; 1993 Jun; 71(17):8E-16E. PubMed ID: 8328370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
